Skip to content

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

Two male doctors looking at a patient's heart with new technology in the OR
  1. Home/
  2. Taking on heart disease

Taking on heart disease

At Johnson & Johnson, we have an unrelenting vision to ease the tremendous global burden of cardiovascular disease. Our medical technologies and therapeutics are helping treat some of the most prevalent heart conditions, driving better outcomes and lasting impact for patients.

Expand
Smart manufacturing fuels our ability to bring these innovations forward with urgency. Digital twins simulate steps in our supply chain and AI-driven predictions help us anticipate when and where our medical products are needed.

By combining deep understanding of technology and science with our people’s determination, we power the future of human health.
Collapse

Innovating in Health&Care

“There’s a growing need to expand the CLTI treatment toolbox”

With new innovations in treating chronic limb-threatening ischemia (CLTI), surgeons are able to modify lesions that were, historically, too challenging to cross.

Do you know what heart failure is? (Hint: It’s probably not what you think)

Learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.

Inside the all-female coronary interventions trial

EMPOWER CAD is a first-of-its-kind study to determine the effectiveness of IVL in women to address a gender gap in coronary artery disease outcomes—and empower female clinicians along the way.

What’s the difference between a heart attack and cardiac arrest?

Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.

Ask an electrophysiologist: What roles do PFA and RFA play in the treatment of AFib?

Both are types of cardiac ablation, but are distinct in a few key ways. An expert weighs in on when and how they can be harnessed.

More from Johnson & Johnson

Juvenile myasthenia gravis: Inside one adolescent’s journey

The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

Teaming up to support healthcare in the local community and empower residents.